483
Somerset Therapeutics LimitedSomerset Therapeutics Limited – FDA 483, Feb 19, 2020
Record Details
Wintac Limited, a sterile drug manufacturer in Bangalore, India, was inspected by the FDA from February 10-19, 2020. The inspection revealed significant deficiencies in aseptic processing validation, microbiological contamination prevention, quality control unit procedures, and laboratory controls. Issues included inadequate media fill studies, lack of continuous environmental monitoring, problems with container/closure leachables, and insufficient investigation and CAPA implementation.
View Company Profile
ID · 3aef1f14-a625-4846-b987-f3e996b7bed6
Other documents for Somerset Therapeutics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.